The Clinical Physics Research of Image Guided Adaptive Radiation Therapy for Esophagus Cancer
NCT02653521 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2017-10-11
Summary
The purpose of this study is to evaluate the benefit of adaptive radiation therapy (adaptive radiation therapy, ART) for esophageal cancer, using dose tracking technique with online images and deformable registration.
Conditions
- Esophageal Cancer
Interventions
- RADIATION
-
Dose adaptation
Replanning the treatment to adapt the change of PTV and movement of OARs to achieve an optimal dose distribution using online CBCT images.
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Principal Investigators
-
Deng Xiaowu, PHD. · Sun Yat-sen University
-
Liu Hui, PHD. · Sun Yat-sen University
-
Peng Yinglin, MD · Sun Yat-sen University
-
Qiu Bo, PHD. · Sun Yat-sen University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-12-30
- Primary Completion
- 2018-12-30
- Completion
- 2019-12-30
Countries
- China
Study Locations
More Related Trials
-
IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients
NCT03910634 ·Status: UNKNOWN ·Phase: PHASE2
-
Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer
NCT02556762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
NCT03660449 ·Status: COMPLETED ·Phase: PHASE2
-
Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal Carcinoma
NCT02429622 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Study on the Mechanism of Radiotherapy-elicited Immune Response
NCT06393140 ·Status: RECRUITING
-
Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
NCT01745107 ·Status: UNKNOWN ·Phase: PHASE3
-
Adaptive Neoadjuvant Therapy for Esophageal Cancer
NCT06990178 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer
NCT02325986 ·Status: UNKNOWN ·Phase: PHASE2
-
Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma
NCT03381651 ·Status: COMPLETED ·Phase: NA
-
Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer
NCT01291823 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Chemotherapy or Chemoradiotherapy in Resectable Oesophageal Carcinoma(NewEC Study)
NCT04027543 ·Status: COMPLETED
-
Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma(EC-CRT-003)
NCT05512520 ·Status: RECRUITING ·Phase: PHASE2
-
The Application of 3T MRI in Esophageal Cancer
NCT03635619 ·Status: UNKNOWN
-
Radiation Dose Study of Concurrent Chemoradiotherapy With Cisplatin Plus Fluorouracil in Oesophageal Cancer
NCT01646853 ·Status: UNKNOWN ·Phase: NA
-
Report of the Survival Outcomes of Patients With Esophageal Cancer After Definitive Radiotherapy in China
NCT05194371 ·Status: COMPLETED
-
Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy
NCT05543057 ·Status: RECRUITING
-
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT02964455 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO
NCT04137679 ·Status: UNKNOWN ·Phase: PHASE2
-
S-1 IMRT Versus S-1 and Cisplatin Concurrent IMRT in Inoperable Esophageal Squamous Cell Carcinoma
NCT02913066 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma
NCT02916511 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Radiation Therapy and Peptide Specific CTL Therapy in Treating Patients With Esophageal Cancer
NCT03011255 ·Status: UNKNOWN ·Phase: PHASE2
-
S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer
NCT01175447 ·Status: COMPLETED ·Phase: PHASE1
-
Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy
NCT03734952 ·Status: RECRUITING ·Phase: NA
-
A Study to Compare Efficacy and Safety of DRT VS CRT Plus Surgery in Patients Who Achieved CCR for Esophageal Cancer
NCT03708042 ·Status: UNKNOWN ·Phase: PHASE3
-
Synchronous or Sequential Radiotherapy for Advanced Esophageal Squamous Cell Carcinoma With Oligometastases.
NCT06143722 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2